tirzepatide semaglutide therapeutic modality for Weight Loss Tirzepatide vs. Semaglutide: Key Differences

Sustarsic EG, et al

Lorenz M, Evers A, Wagner M (2013) Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity

The decision to start semaglutide should include a conversation about realistic timelines, potential side effects like nausea or appetite suppression, and commitment to ongoing lifestyle support

The stimulant properties of phentermine could exacerbate anxiety or sleep disturbances, affecting quality of life and mental wellbeing

We may not always be able to fulfil such a request, particularly when we still need the data for an ongoing contract or when keeping certain data is legally required

[,] Since 2016, GLP-1RAs, approved for type 2 diabetes mellitus (T2DM) and obesity, have also shown cardiovascular safety